Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Diabetic Retinopathy - High Risk”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT00511875
What this trial is testing

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Thomas Gardner 30
Not applicableStudy completedNCT03660384
What this trial is testing

Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy

Who this might be right for
Diabetic RetinopathyRetinal Detachment
Rush Eye Associates 302
Post-approval studies (Phase 4)Active Not RecruitingNCT07118670
What this trial is testing

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Edward Wood, MD 40
Not applicableLooking for participantsNCT06899529
What this trial is testing

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Christian Ophthalmic Surgery Expedition Network 150
Testing effectiveness (Phase 2)Study completedNCT01280929
What this trial is testing

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy

Who this might be right for
High Risk Proliferative Diabetic Retinopathy
José Cunha-Vaz 54
Testing effectiveness (Phase 2)Study completedNCT01102946
What this trial is testing

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyRetinal Neovascularization
University of Sao Paulo 40
Not applicableStudy completedNCT06653361
What this trial is testing

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Hayatabad Medical Complex 120
Not applicableStudy completedNCT02995629
What this trial is testing

Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Wills Eye 40
Post-approval studies (Phase 4)Looking for participantsNCT06662994
What this trial is testing

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Who this might be right for
Diabetic Macular Edema (DME)
Retina Consultants of Orange County 15
Not applicableStudy completedNCT01009021
What this trial is testing

Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy

Who this might be right for
Pain
University of Sao Paulo 30
Testing effectiveness (Phase 2)UnknownNCT02630277
What this trial is testing

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN

Who this might be right for
Proliferative Diabetic Retinopathy
Valley Retina Institute 30
Testing effectiveness (Phase 2)Study completedNCT01281098
What this trial is testing

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Who this might be right for
High Risk Proliferative Diabetic RetinopathyDiabetes Mellitus Type IDiabetes Mellitus Type II
Association for Innovation and Biomedical Research on Light and Image 22
Large-scale testing (Phase 3)Study completedNCT01941329
What this trial is testing

Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.

Who this might be right for
High Risk Proliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 94